T1	Treatment 511 522	Defibrotide
T2	Treatment 572 587	calcium heparin
T3	Treatment 821 859	Defibrotide at a dose of 400 mg b.i.d.
T4	Treatment 860 864	i.v.
T5	Treatment 865 957	in 50 ml phleboclysis in 5 minutes (n = 108); 2) calcium heparin at a dose of 5000 IU t.i.d.
T6	Treatment 958 982	subcutaneously (n = 103)
T7	Treatment 984 1101	The treatment began the day before operation and continued on average up to the eighth day for the Defibrotide group.
T8	Treatment 1296 1307	Defibrotide
T9	Treatment 1842 1853	Defibrotide
T10	Treatment 2109 2120	Defibrotide
